Cargando…
Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models
BACKGROUND: Increased concentrations of choline-containing compounds are frequently observed in breast carcinomas, and may serve as biomarkers for both diagnostic and treatment monitoring purposes. However, underlying mechanisms for the abnormal choline metabolism are poorly understood. METHODS: The...
Autores principales: | Moestue, Siver A, Borgan, Eldrid, Huuse, Else M, Lindholm, Evita M, Sitter, Beathe, Børresen-Dale, Anne-Lise, Engebraaten, Olav, Mælandsmo, Gunhild M, Gribbestad, Ingrid S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931488/ https://www.ncbi.nlm.nih.gov/pubmed/20716336 http://dx.doi.org/10.1186/1471-2407-10-433 |
Ejemplares similares
-
Interplay of choline metabolites and genes in patient-derived breast cancer xenografts
por: Grinde, Maria T, et al.
Publicado: (2014) -
Differential In Vivo Tumorigenicity of Distinct Subpopulations from a Luminal-Like Breast Cancer Xenograft
por: Skrbo, Nirma, et al.
Publicado: (2014) -
Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer
por: Moestue, Siver A, et al.
Publicado: (2013) -
Merging transcriptomics and metabolomics - advances in breast cancer profiling
por: Borgan, Eldrid, et al.
Publicado: (2010) -
Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model
por: Kim, Eugene, et al.
Publicado: (2016)